Discovery of Novel Antiviral Scaffolds, Potent Inhibitors of Respiratory Syncytial Virus Fusion
Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, older adults, andother vulnerable populations. Although three vaccines have recently been approved to prevent RSV infection inpregnant women and adults aged 60 years and above, there remains a significant unmet need f...